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 Antigen-presenting cells (APCs), such as dendritic cells
(DCs), macrophages, and B cells, serve as the immune senti-
nels to the foreign world. DCs are characterized by expres-
sion of major histocompatibility complex (MHC) molecules,
a dendritic appearance, and the capacity for presenting anti-
gens [1-3]. They are more potent than macrophages in initiat-
ing and perpetuating secondary immune responses, and play a
pivotal role in immunity and immune tolerance [4]. Macroph-
ages are another important population of APCs. These cells
are involved not only in antigen presenting processes and ph-
agocytosis [5], but also in immune regulation in other organs
and tissues due to their active secretion of a range of impor-
tant biologically active molecules [6,7]. It has been shown
that costimulatory molecules B7-1 and B7-2 are expressed on
the surface of APCs and are involved in the activation of T
cells. APCs with B7-1 mainly stimulate Th1 cells, whereas
APCs with B7-2 activate Th2 cells and induce immune toler-
ance by producing IL-10 and IL-4 [8,9]. A recent study has
shown that B7-1 and B7-2 are critical in the induction of ante-
rior chamber-associated immune deviation (ACAID), a sys-
temic tolerance induced by injection of soluble antigen into
the anterior chamber of the eye [10]. Therefore, it seems likely
that under certain conditions, B7-1 and/or B7-2 not only pro-
mote activation of T cells but also participate in the induction
of immune tolerance. APCs have been found in ocular tissues
such as the uveal tract [11-13], retina [14-16] and cornea [17-
19]. The majority of the bone marrow (BM)-derived cells in
the mouse iris-ciliary body was shown to be of macrophage
and DC lineage. These APCs, particularly F4/80+ monocytes/
macrophages, have been proposed as one of the immune regu-
latory components within the anterior segment of the eye that
is involved in the induction of ACAID [20,21]. Moreover, as
a soluble protein, ovalbumin (OVA) can be ingested, processed,
and presented by professional APCs. The processing speed of
OVA inside APCs is sufficiently slow to allow OVA to serve
as an effective tracer reagent to study the characteristics of
APCs [22].
In view of the fact that the cornea directly contacts the
external environment, it is important to address the role of
APCs in this tissue. Previous studies examining the cornea
©2007 Molecular Vision
Phenotypes, distribution, and morphological features of antigen-
presenting cells in the murine cornea following intravitreal
injection
Qianli Meng,1 Peizeng Yang,1 Haoli Jin,2 James T. Rosenbaum,3 Bing Li,1 Haining Zhang,1 Hongyan Zhou,1
Xiangkun Huang,1 Stephen R. Planck3
1Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology and 2Uveitis Study Center, Sun Yat-Sen University,
Guangzhou, P.R. China; 3Departments of Ophthalmology, Cell and Developmental Biology, Medicine, Casey Eye Institute, Oregon
Health & Science University, Portland, OR
Purpose: To study the phenotypes, distribution, and morphologies of different antigen-presenting cells (APCs) in the
murine cornea.
Methods: Intravitreal injection of fluorescently tagged ovalbumin (OVA) or antibodies to MHC-II (I-Ad), F4/80, CD11c,
B7-1, and B7-2 was performed to label cells in the murine cornea. Light and transmission electron microscopy were used
to examine corneal histology. Intravital microscopy, epifluorescence microscopy, and confocal microscopy were used to
evaluate the labeled cells. In vitro staining was performed to validate the in vivo staining and localize the labeled cells.
Three-dimensional rotatable images were taken to evaluate relationships between two differently labeled cells.
Results: Histological examination revealed no observable change in the cornea following intravitreal injection. In vivo
staining showed that OVA+ cells and cells positive for MHC-II, F4/80, CD11c, B7-1, or B7-2 were noted throughout the
cornea with a decreasing density from limbus toward the central cornea. Two populations with distinct morphological
features were identified among these APCs. Labeled cells were found beneath the epithelium or in the shallow stroma in
the central and paracentral cornea, but in all layers in the peripheral cornea. A number of F4/80+ and CD11c+ cells were
also positive for OVA, MHC-II, B7-1, or B7-2. Rotatable images showed a close contact between two differently labeled
cells.
Conclusions: Intravitreal injection of labeled antibodies can be adapted to visualize labeled cells in the cornea. APCs with
distinct morphologies, phenotypes, and distribution may contribute to the immunologically privileged feature of the cor-
nea.
Correspondence to: Prof. Dr. Peizeng Yang, Zhongshan Ophthalmic
Center, Sun Yat-Sen University, 54 South Xianlie Road, Guangzhou,
510060, P.R. China; Phone: 0086-20-87330402; FAX: 0086-20-
87330403; email: peizengy@126.com
Dr. Jin is now at the Division of Immunology, Children’s Hospital-
Boston, Harvard Medical School, Boston, MA, 02115
475for APCs have largely relied on the expression of MHC-II
antigens. The MHC-II+ cells were primarily found in the lim-
bus and peripheral cornea of the guinea pig, hamster, mouse,
and human [17-19,23-26]. However, the phenotype of these
cells and their presence in the central cornea remains contro-
versial [23,27-29]. Recent studies [30,31] identified distinct
subtypes of DCs with either BM-derived DC or Langerhans
cell characteristics in the murine corneal tissues. Brissette-
Storkus et al. [32] have shown that the BM-derived cells that
predominantly reside in the cornea stroma are macrophages.
However, the phenotype, distribution, and morphological fea-
ture of APCs in the murine cornea have not been well charac-
terized. To address these issues, the present study extensively
examined murine corneal APCs by combining intravitreal in-
jection of fluorescently tagged OVA and antibodies, intravital
microscopy, whole mount ocular tissue processing, and con-
focal microscopy techniques. Based on the morphological fea-
tures, we identified APCs of two major phenotypes through-
out the cornea with a decreasing density from limbus toward
the central cornea.
METHODS
Animals:  Female BALB/c mice from the animal facility at
Sun Yat-Sen University (GuangZhou, China), 6-8 weeks of
age and 20-26 g body weight, were used for histological ex-
amination, slit lamp microscopy, epifluorescece microscopy,
and confocal fluorescence microscopy observation. A subset
of studies including intravital microscopy, epifluorescece mi-
croscopy, and confocal fluorescence microscopy were also
conducted on BALB/c mice with the same age and body weight
housed in the animal care facilities of the Oregon Health &
Science University. All experiments were performed in accor-
dance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
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TABLE 1. GROUPS DESIGNED FOR IN VIVO IMMUNOFLUORESCENT
STAINING
To visualize the labeled cells in the cornea, fifty-one BALB/c mice
were divided into 17 groups and 2 µl of fluorescently tagged OVA or
antibodies were injected into these murine vitreous bodies, respec-
tively, according to designed combinations. Except for OVA, all were
antibodies against the indicated cell surface molecules.
TABLE 2. ANTIBODIES USED IN THIS STUDY AND THEIR SPECIFICITIES
Different antibodies were used to examine the immune cells of the murine cornea. All primary antibodies and OVA were conjugated with
either Alexa Fluor 488 (green) or Alexa Fluor 594 (red) using the Monoclonal Antibody Labeling Kit according to the manufacturer’s (Mo-
lecular Probes, Eugene, OR) instructions.
476Histological examination:  Corneas were examined un-
der a dissection microscope before intravitreal injection, and
only those without signs of inflammation or other abnormali-
ties were used in the studies. In order to assess if the injection
technique itself altered corneal APCs, six normal BALB/c mice
were anesthetized by inhalation of 1.7% isoflurane in oxygen.
A glass micropipette (approximately 80 µm diameter) was fit-
ted onto a sterile infant feeding tube and mounted onto a 0.1
ml Hamilton syringe. A Hamilton automatic dispensing appa-
ratus was used to inject two µl isotype controls into the right
eye vitreous body. The left eyes were used as controls. Twenty-
four h later, the mice were sacrificed and the enucleated eyes
were used for light and transmission electron microscopy. Six
eyes (including 3 injected eyes and 3 normal eyes) were fixed
in 4% paraformaldehyde for 24 h and used for light micro-
copy. Paraffin sections (5 µm) were prepared and stained with
hematoxylin and eosin (H&E). The other 6 eyes were fixed in
2.5% buffered glutaraldehyde overnight and then in 1% os-
mium tetroxide for 1.5 h at 4 °C. The corneal tissues were
then dehydrated in a graded ethanol series and embedded in
Epon. Ultrathin sections were cut at 50 nm, stained in aque-
ous 2% uranyl acetate, and viewed under a H600 transmis-
sion electron microscope (Hitachi, Tokyo, Japan).
In vivo immunofluorescent labeling:  Intravitreal injec-
tion of fluorescently labeled reagents was performed on six
mice after they were anesthetized as described above. At 1, 4,
8, 12, and 24 h after this injection, the mice were examined
with a slit lamp microscope while awake. Our result showed
that intensified fluorescence was observed at 1 h and thereaf-
ter. This result indicated that the intravitreously injected
fluorescently labeled reagents could readily enter the anterior
chamber. For the purpose of visualizing the labeled cells in
the cornea, 2 µl of fluorescently tagged OVA (50 µg) or anti-
bodies were injected into the vitreous body of BALB/c mice
as described above (Table 1 and Table 2). These mice were
anesthetized with one l/min of 1% to 2% isoflurane in oxygen
and the labeled cells in the cornea were visualized by intravi-
tal microscopy as described previously [33] at 4, 12, and 24 h
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Figure 1. Histology of the cornea, iris-ciliary body, and retina in the normal mouse and the mouse receiving intravitreal injection.  Light
micrograph of the normal cornea, iris-ciliary body, and retina (A,C) and the cornea, iris-ciliary body, and retina of mice receiving intravitreal
injection (B,D). The corneal epithelium, endothelium, and stroma are arranged in order and no inflammatory cells and edema are observed.
477after injection. The microscopic images were captured by a
Kappa CF11 DSP color video camera coupled to an image
intensifier and recorded at 30 frames/s and 500x350 pixels.
The mice were sacrificed at 24 h after injection and the
eyes were immediately removed and fixed in 4% paraformal-
dehyde in the dark for 4-6 h at 4 °C. Corneal whole-mount
specimens were prepared as previously reported [34] and flat-
tened by multiple radial cuts from the limbus to the paracen-
tral area. The corneal whole-mounts were placed on slides with
the epithelium facing upwards, embedded in Slow Fade
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Figure 2. Ultrastructure of the cornea from the normal mouse and the mouse receiving intravitreal injection.  Electron micrograph of the
normal cornea (A: epithelium, C: endothelium) and the cornea of mouse receiving intravitreal injection (B: epithelium, D: endothelium). The
mitochondrion has no ectasia, the mitochondrial outer and inner membranes are intact, and the mitochondria cristae arrange normally. The
endoplasmic reticulum does not dilate. The nuclear membrane has integrity and the chromatin is distributed uniformly. The intercellular
substance does not broaden and the cellular junctions were normal. The arrows indicate the location of different microorganelles. M: mito-
chondrion, E: endoplasmic reticulum, N: nuclear membrane; C: chromatin, J: cellular junction. The magnification in A and B is 12,000X while
the magnification in C and D is 22,500X.
478antifade mounting medium (Molecular Probes, Eugene, OR)
and covered. Standard epifluorescence microscopy with
Axioplan 2 imaging and Axiophot 2 universal microscopes
(Carl Zeiss, Germany) and confocal fluorescence microscopy
with LSM 510 and LSM 510 META laser scanning micro-
scopes (Carl Zeiss) were used to examine the labeled cells in
the corneal whole-mounts. Three-dimensional rotatable im-
ages were generated using 64 sections from confocal micros-
copy with the Zeiss LSM analysis software.
Frozen sections were also made from additional mice that
received intravitreal injection of the same reagents or anti-
bodies. At 24 h after injection, the eyes were embedded in
OCT and frozen immediately. Longitudinal sections with 5
µm thickness were made and viewed by epifluorescence mi-
croscopy.
In vitro immunofluorescent staining:  Corneal whole-
mounts were isolated from normal BALB/c mice using the
procedure described above. Corneal tissues were fixed for 30
min at 4 °C in 1% paraformaldehyde-PBS followed by exten-
sive washing with PBS. To block nonspecific staining, cor-
neas were incubated in PBS containing 2% bovine serum al-
bumin for 15 min at room temperature and subsequently were
blocked for 20 min at 37 °C with 10 µg/ml anti-FcγIII/II re-
ceptor monoclonal antibody (CD16/CD32; BD Biosciences
Pharmingen, San Diego, CA) diluted in PBS. Afterward, cor-
neas were immunostained with MHC-II, F4/80, or CD11c
(1:40) or isotype-matched control antibodies for 2 h at room
temperature. Finally, the corneas were mounted according to
the method stated above and observed with epifluorescence
microscopy.
Statistical analysis:  To compare the density of
fluorescently labeled cells in different portions of the cornea,
the cornea, roughly 3.3 mm in diameter, was divided into four
parts: central, paracentral, peripheral, and limbus according
to the method described previously [17]. Labeled cells were
counted using a calibrated eyepiece graticule under an
epifluorescence microscopy with a 20X objective lens. Count-
ing was performed randomly in three separate fields of each
unique area in the corneal whole-mounts, and the average den-
sity per square millimeter of cells was expressed as mean±SD.
The randomized block design was used to compare the differ-
ence in cell density among different portions of the same cor-
nea, and a p<0.05, as determined by the student’s T-test, was
considered significant. The number of eyes used for statistical
analysis is shown in Table 1.
RESULTS
 To examine whether intravitreal injection of 2 µl reagent could
result in a visible change, we investigated the cornea using
light and transmission electron microscopy. Light microscopy
revealed that there was no change in the cornea, iris-ciliary
body and retina from mice receiving intravitreal injection and
that no inflammatory cells or edema were observed in the an-
terior segment of the eye (Figure 1). Transmission electron
microscopy revealed a normal mitochondrial appearance and
arrangement. There were no pathological changes in the cel-
lular junction, endoplasmic reticulum, nuclear membrane,
chromatin, and intercellular substance (Figure 2).
Slit lamp microscopy was used for observing the distri-
bution of injected fluorescently labeled reagents. Intense fluo-
rescence was observed in the anterior chamber at 1 h (Figure
3) and was followed by a gradual decrease in the fluorescent
intensity from 4 to 24 h after intravitreal injection. At 24 h
after injection, the intensity of fluorescence in the anterior
chamber was weak and the iris could be clearly seen. No sub-
conjunctival accumulation of fluorescence was observed at
any time point after intravitreal injection of the fluorescently
labeled reagents.
Cells positive for OVA, MHC-II, F4/80, CD11c, B7-1, or
B7-2 were intravitally observed in different portions of the
cornea by 4, 12, and 24 h after intravitreal injection. In gen-
eral, the background was very strong and labeled cells were
vaguely observable at 4 and 12 h (Figure 4). By 24 h, back-
ground staining was much less and labeled cells could be
clearly seen. Therefore, mice were sacrificed at 24 h and the
corneas were evaluated using epifluorescence and confocal
microscopy. The two techniques provided similar results. There
were too many labeled cells to count in the limbus. A gradu-
ally decreasing density of labeled cells was noted from lim-
bus towards the central cornea regardless of the fluorescent-
conjugated reagent used. Except for the B7-1+ cells, the den-
sity of different labeled cells was significantly different among
peripheral, paracentral, and central cornea (p<0.05; Figure 5
and Figure 6A-F). Cells labeled with OVA usually showed
somewhat stronger staining as compared with antibody-labeled
cells. Staining using isotype control antibodies was rarely de-
tected in corneal cells, therefore excluding appreciable non-
specific uptake of antibody.
As shown in Table 3, at least two morphologically differ-
ent populations of cells were labeled for MHC-II, CD11c, F4/
80, B7-1, or B7-2 in the murine cornea. However, morpho-
logical features were different for the each surface marker.
For the MHC-II+ cells, approximately two thirds of them had
a dendritic appearance with a small cell body, many long den-
drites, and intense staining (Figure 6G). These cells were found
at the limbus, peripheral, and paracentral cornea, but were un-
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Figure 3. Slit lamp microscopy on the anterior segment after
intravitreal injection of fluorescently labeled reagents.  Intense fluo-
rescence was observed in the anterior chamber 1 h after intravitreal
injection of green fluorescently labeled OVA using slit lamp micros-
copy. (A: showing the fluorescence in the whole anterior chamber;
B: showing the fluorescence in the central anterior chamber.)
479detectable in the central area (Figure 6A-C). The other one
third of MHC-II+ cells possessed round or irregular shapes
with a large cell body, a few, short dendrites, and weak stain-
ing (Figure 6H). These cells were seen throughout the cornea
in a decreasing cell density from the limbus toward the center.
The morphological characteristics of CD11c+ cells were simi-
lar to those of MHC-II+ cells (Figure 6I). The majority of F4/
80+, B7-1+, and B7-2+ cells were round, oblong, or irregular,
with a large cell body and a few, short dendrites (Figure 6J,K).
Theses cells were dense in the peripheral area, where they
were extremely elongated (Figure 6L), and also extended
through the paracentral region, where they were slightly ra-
mose (Figure 6M), and into the central cornea where they were
more round or oblong (Figure 6N). Some cells were bright,
while others were weakly stained. With a careful examination
at medium-power magnification of 400X, we noted that a
minority of F4/80+, B7-1+, and B7-2+ cells, similar to the first
population of MHC-II+ cells, was also dendriform. However
their staining was weaker. OVA+ cells, like F4/80+, B7-1+, and
B7-2+ cells, were visualized throughout the cornea with a de-
creasing density from peripheral to central areas (Figure 6D-
F). These cells exhibited a round, oblong, or irregular shape
in the murine cornea (Figure 6O).
To examine the phenotypes of these positively labeled
cells in the murine cornea, we costained the cornea using the
antibody and OVA combinations as listed in Table 1 (Group 7
to 16). About 90% of F4/80+ and 57% of CD11c+ cells, mostly
showing round or irregular shapes, were positive for OVA
(Figure 7A,B). Only about 25% of F4/80+ cells were posi-
tively costained with anti-CD11c (Figure 7C). Approximately
91% of CD11c+ cells and 69% of F4/80+ cells were MHC-II
positive (Figure 7D,E). Approximately 60% of CD11c+ cells
(Figure 7F) and 50% of F4/80+ cells were B7-1 or B7-2 posi-
tive. About 52% of OVA+ cells were MHC-II+ cells with round
or irregular appearance (Table 4). There was no difference
between peripheral and central cornea regarding the
coexpressive ratios of cell surface markers.
To assess the locations of the positively labeled cells in
the anterior-posterior axis of the murine cornea, frozen sec-
tions were prepared following in vivo immunofluorescent
staining. Cells positive for OVA and F4/80 were detected be-
neath the epithelium or in the anterior stroma and paralleled
the arrangement of corneal collagen fibrous sheets in the cen-
tral and paracentral cornea. However, these cells were present
in all layers of the cornea at the peripheral part (Figure 8A,B).
The locations of MHC-II+ and CD11c+ cells were similar to
those of OVA+ and F4/80+ cells, except that dendrites project-
ing longitudinally into the epithelium or into the stroma were
occasionally seen (Figure 8C).
Three-dimensional rotatable images disclosed a close re-
lationship between certain labeled cells. Interestingly, a few
cells seemed to contact each other at a portion of the cell body
or the dendrites (Figure 9), although the physiological role of
these contacts remains to be investigated.
To validate the in vivo staining experiments and elimi-
nate the possibility that cells were labeled because of nonspe-
cific antibody ingestion, we performed the in vitro immunof-
luorescent staining using antibodies to MHC-II, F4/80 and
CD11c. Cells identified in the cornea were comparable with
those observed by in vivo staining. However, the in vitro stain-
ing resulted in a stronger background and the labeled cells
were vaguely observed (Figure 10).
DISCUSSION
 Using confocal fluorescence microscopy and other techniques
after intravitreal injection of fluorescently tagged antibodies,
we have demonstrated that there are at least two populations
of APCs with a decreasing density from limbus towards cen-
ter in the murine cornea. All the positively labeled cells were
found beneath the epithelium or in the anterior stroma in the
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Figure 4. Intravital micrography of OVA+ cells in the murine cor-
nea.  OVA+ cells in the paracentral region of the murine cornea are
detected by intravital microscopy 12 h after intravitreal injection
(X200). The background is somewhat stronger.
Figure 5. Differently labeled cells in the normal murine cornea.  Den-
sity of differently labeled cells in the normal murine cornea (cells/
mm2). A significant difference (p<0.05) in cell density among three
portions (periphery, paracenter, and center) of the normal cornea is
noted for all but B7-1+ cells (asterisk).
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Figure 6. Distribution and morphology of labeled cells in the murine cornea at 24 h after intravitreal injection of fluorophore-conjugated
reagents.  A decreasing density of positive cells is observed from peripheral to central cornea (A,D: peripheral cornea, B,E: paracentral cornea,
C,F: central cornea. A-C: MHC-II+ cells, D-F: OVA+ cells). Two populations of each antibody labeled cells, i.e., dendriform (G: MHC-II+ cell,
I: CD11c+ cells) and round or irregular shapes (H: MHC-II+ cell, I: CD11c+ cells, J: F4/80+ cell, K: B7-1+ cell) are identified. F4/80+ cells seem
to be more elongated in the peripheral area (L), slightly ramose in the paracentral region (M), and more round or oblong in the central cornea
(N). All OVA+ cells show round, oblong or irregular shapes (O).
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TABLE 3. MORPHOLOGICAL FEATURES AND DISTRIBUTION OF POSITIVE CELLS IN THE MURINE CORNEA
Morphological features and distribution of labeled cells in the murine cornea at 24 h after intravitreal injection of fluorophore-conjugated
reagents were observed using confocal fluorescence microscopy. The corneas were examined at medium-power magnification (400X).
Figure 7. Phenotypes of APCs in the normal cornea shown in confocal microscopy images.  Corneas are double stained in vivo with OVA and
antibodies, followed by examination of wholemounts under the confocal microscopy. A number of F4/80+ (A: green) and CD11c+ (B: green)
cells are positive for OVA (A,B: red). A few of F4/80+ cells are positively costained with anti-CD11c (C: red F4/80, green CD11c). A number
of CD11c+ cells (D: green) and F4/80+ cells (E: red) are also MHC-II positive (D: red, E: green). More than half of CD11c+ cells are double
stained for B7-2 (F: red CD11c, green B7-2). Double-labeled cells are yellow.
482central and paracentral cornea but were noted in all layers of
the peripheral cornea. Double staining revealed that a number
of F4/80+ and CD11c+ cells were also positive for OVA, MHC-
II, B7-1, or B7-2. Rotatable images showed a close contact
between certain labeled cells.
Previously we used an intravital microscopy technique to
visualize cells in the iris labeled via injecting relevant reagents
or antibodies into the anterior chamber [35]. However, this
route of injection could damage the cornea despite cautions
taken during the injection. In this study, we developed a use-
ful method of labeling cells in the cornea by intravitreal injec-
tion of fluorescently tagged reagents coupled with intravital
microscopy and confocal fluorescence microscopy. Using these
techniques, our study showed that the injected reagents readily
enter the anterior chamber, as evidenced by intense fluores-
cence in the anterior chamber shortly after intravitreal injec-
tion. Although a barrier was generally thought to be present at
the endothelial level of the cornea, these fluorescently labeled
reagents could subsequently penetrate into the cornea with
negligible damage to the eye. As a result, labeled cells could
be clearly observed using confocal microscopy and there was
only weak background in the corneal whole-mounts at 24 h.
In order to compare the similarity between in vivo staining
and in vitro staining, two complementary experiments, i.e., in
vitro staining and isotype-matched control antibody staining
were performed to exclude the artifactual effect and validate
results of the in vivo staining. In vitro immunofluorescent stain-
ing of corneal wholemounts also demonstrated that the posi-
tively labeled cells were not the result of nonspecific inges-
tion of antibodies. Cell morphologies and distributions ac-
quired from these in vitro staining results were essentially iden-
tical to those of in vivo staining, indicating the de facto pres-
ence of these cells in the cornea. Moreover, the control ex-
periment using isotype-matched immunoglobulin excluded the
possibility of nonspecific staining.
Our study showed that intravitreal injection of
fluorescently labeled antibodies did not influence the cornea
histologically or ultrastructurally. In conventional histologi-
cal or immunohistochemical studies, one cannot eliminate the
possibility that death and/or fixation alter the detection of cell
surface molecules. Comparing fixed tissue staining with stain-
ing of live tissue, we believe that background staining is mini-
mized in vivo. In fact, this technique omits a number of pro-
cedures and reagents used in in vitro experiments, thereby
enhancing the reliability of the results. Moreover, intravitreal
injection of fluorescently labeled antibodies may allow a dy-
namic observation on the labeled cells in the cornea using in-
travital microscopy. Therefore, combination of intravitreal
injection of labeled reagents with intravital microscopy may
be a useful technique to follow changes of immune cells in
the cornea.
APCs in the cornea have received enormous attention
during the past decades, mainly because of the concept that
the cornea is an immunologically privileged tissue. Our stud-
ies confirm the previously described results in which APCs
are distributed more densely in the limbus and peripheral cor-
nea than in the paracentral or central cornea [17]. Numerous
APCs are present in the limbus and in the portion of the cor-
nea adjacent to it. The densely distributed APCs in the limbus
and peripheral cornea are of great importance to the immune
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Figure 8. Location of labeled cells in the vertical axis of the cornea.  Frozen sections are prepared and stained with antibodies and OVA,
followed by epifluorescence microscopy examination. OVA+ cells are distributed beneath the epithelium in the central part (A) and present in
all layers of the peripheral cornea (B). The dendrites projecting from MHC-II+ cells are present longitudinally into the epithelium and stroma
(C). Arrowheads indicate the epithelium location and the arrow indicates the location of endothelium.
TABLE 4. COEXPRESSION OF CELL SURFACE MARKERS ON NORMAL
MURINE CORNEAL CELLS
To examine the phenotypes of these positively labeled cells in the
murine cornea, the cornea were costained with the combinations of
antibodies and OVA in two-color phenotype analysis.
483surveillance in the cornea and may also be pathologically in-
volved in the development of inflammatory diseases frequently
seen in the peripheral cornea [36]. Frozen sections revealed
that all of the positive cells were located beneath the epithe-
lium or in the anterior stroma and paralleled the arrangement
of corneal collagen fibers in the central and paracentral cor-
nea. Three-dimensional images obtained using confocal mi-
croscopy disclosed a flat-shaped morphology of the labeled
cells in the central or paracentral cornea, with a few dendrites
of MHC-II+ and CD11c+ cells projecting longitudinally into
the corneal epithelium or stroma. The morphological features
and arrangement of these APCs in the cornea may not only
allow the light to readily enter the eye but also contribute to
the corneal transparency.
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Figure 9. Three-dimensional rotatable confocal microscopy images for observing the relationship between labeled cells.  The MHC-II+ cell
contacts an OVA+ cell at a portion of the cell body and the dendrite (A: the frontal image, B: the lateral image; red OVA, green MHC-II).
Figure 10. MHC-II positive
cells stained in vivo and in
vitro shown by epifluorescence
microscopy.  MHC-II+ cells
stained in vivo 24 h after
intravitreal injection (A and C)
and in vitro (B and D) in the
paracentral region of the mu-
rine cornea are observed by
epifluorescence microscopy.
The background in vitro stain-
ing is stronger than that in vivo
staining. The labeled cells in
vitro staining appear to be
vaguely seen as compared with
those in vivo staining.
484Our studies revealed that a number of OVA+ cells were
positive for CD11c and F4/80, suggesting that these cells might
be able to take up and process foreign proteins and probably
belonged to the macrophage and DC lineages. Most F4/80+
cells were positively stained for OVA, indicating that they
probably had a strong ability to phagocytose or pinocytose
antigens. About a quarter of these F4/80+ cells might be DCs
because they were positive for CD11c. These results are con-
sistent with the notion that the monoclonal antibody to F4/80
recognizes both macrophages and DCs [37]. Almost all CD11c+
cells were MHC-II positive, suggesting that the phenotype of
primary antigen-presenting cells in the cornea was
CD11c+MHC-II+. Moreover, we found that a subset of F4/80+
or CD11c+ cells in the central and peripheral cornea were posi-
tive for either B7-1 or B7-2. It is worthwhile to mention that
the cornea contains different subsets of APCs with distinct
morphological features and that these APCs are partially
CD11c and F4/80 positive [30-32,38]. We detected cells ex-
pressing B7-1 and B7-2 in the central cornea more readily
than in one report [31] and we detected CD11c more readily
than was noted in vitro [32]. The discrepancies of these re-
sults may lie in the techniques employed. Our in vivo labeling
technique may allow the antibodies to penetrate into the cor-
nea more readily than did the antibodies in in vitro experi-
ments. The combination of in vivo staining with confocal mi-
croscopy of high resolution and sensitivity provides more pre-
cise evaluation on labeled cells in the cornea.
APCs have been suggested to play a pivotal role in initi-
ating an immune response or inducing an immune tolerance
within the cornea [39]. Using three-dimensional rotatable im-
aging, our study showed that a few positive cells appeared to
contact each other, suggesting a cell-cell communication be-
tween certain cells. Although we do not know how these cells
interact and whether the contact between them is specific or
nonspecific, this direct intercellular contact may have impor-
tant implications, both physiologically and pathologically.
In conclusion, we have developed a technique to study
the morphologies and phenotypes of corneal cells by inject-
ing fluorescently tagged antibodies into the vitreous body. Our
study confirms the heterogeneity of corneal APCs and includes
three novel observations. First, we have shown that these APCs
can be identified using immunohistology in vivo. This tech-
nology will allow cell populations to be tracked in living ani-
mals. Second, we have shown that antibodies that are injected
intravitreally readily enter the murine cornea. Third, we have
shown a surprising juxtaposition of APCs within the cornea, a
physical contact that may facilitate biological important inter-
actions. Together with other factors in the ocular microenvi-
ronment, APCs with distinct morphologies, phenotypes and
distribution in the cornea regulate the immune response and
maintenance of the immunological privilege of the cornea.
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